Youth OCD Research Study
Help further research on youth OCD by joining Baylor College of Medicine’s research study.
Fast Facts
Taking a medication for OCD
Receive 12-18 Weeks of Cognitive Behavioral Therapy
Ages 7-17
Located in Texas
Study Background
Researchers at Baylor College of Medicine are looking for youth experiencing OCD symptoms and taking medication for OCD.
Help further research for youth obsessive-compulsive disorder (OCD) by joining our research study.
We are conducting a research study that provides cognitive behavioral therapy (CBT) with exposure and response prevention (ERP) for youth aged 7-17 with obsessive-compulsive disorder who are taking medication for OCD.
The goal of the study is to determine whether CBT can help discontinue medication for OCD without relapse over 24 weeks.
Study Background
Researchers at Baylor College of Medicine are looking for youth experiencing OCD symptoms and taking OCD medication.
Help further research for youth obsessive compulsive disorder (OCD) by joining our research study.
We are conducting a research study that provides cognitive behavioral therapy (CBT) with exposure and response prevention (ERP) for youth aged 7-17 with obsessive-compulsive disorder who are taking OCD medication.
The goal of the study is to determine whether CBT can be helpful to discontinue OCD medication without relapse over 24 weeks.
Additional Information
To determine whether cognitive behavioral therapy (CBT) can be helpful for children with obsessive-compulsive disorder (OCD) to discontinue their medication without relapse over 24 weeks.
Your child may qualify for this study if the following criteria are met:
Inclusion Criteria:
Youth ages 7-17
Child experiences OCD symptoms
Child is taking a medication for OCD
Parent and child live in Texas
Exclusion Criteria:
- Parent and/or child does not speak English
There are two parts to this study.
Part 1: Your child will receive CBT for 12 to 18 weeks and continue taking their medication.
Following the completion of Phase I, your child will complete an assessment to determine eligibility for Phase II.
Part 2: At the beginning of Part II, your child will be randomly assigned, like a flip of a coin, to one of two groups:
- Continued antidepressant medication (no changes to medication)
- Discontinuation of their medication (during which they will slowly titrate off of their medication)
Your child will continue to receive CBT throughout this phase. All CBT sessions and medication visits will be done virtually and are free of charge.
Additional procedures:
Throughout the study, your child will meet with one of our study psychiatrists for medication management.
In addition to treatment, you and your child will participate in 4 assessments throughout the study. This includes the initial baseline visit, an assessment after Phase I, an assessment after Phase II, and a 12-month follow-up.
There is no cost for you to enroll in this study. If you choose to enroll your child to our research study, they will partake in Cognitive Behavioral Therapy.
